From Belgium to the US, World Leaders in Biotech

Jun 4 2013

Program Overview:
You are cordially invited to hear from top executives from selected Belgian life science organizations, government agencies and biotech startups. If you are looking to find out more about Europe's hotbed in biotech, Belgium is the place to look. Historically a key region for pharmaceuticals, with the fastest Phase 1 approval process and the highest number of clinical trials per capita of Europe, Belgium has become a world renowned place where biotech and biopharma breakthroughs are translated into successful companies.

9:30am | Registration & Coffee

10:00am | Welcome 
          Diego Miralles, Head of Janssen R&D Center San Diego and Janssen Labs
          Duane Roth, CEO, CONNECT
          Tom Heyman, CEO and Chairman, Janssen Pharmaceutica
          Claire Tillekaerts, CEO FLANDERS INVESTMENT AND TRADE

10:45am | Guided Tour of Janssen Labs

11:30am | Networking Lunch

12:30pm | Presentations 
          H.E. Jean-Claude Marcourt
, VP of the Government of Wallonia & Minister of
          Belgium, the Place to Be For Biopharmaceutical R&D and Manufacturing
          Yves Verschueren
, Managing Director, essenscia
          The San Diego Biotech Scene
          Magda Marquet, Chair of the Board of Directors, BIOCOM   

VIB - the Center of Excellence in Life Science Research in Flanders
Johan Cardoen, Managing Director VIB, Flemish Institute for Biotechnology
          The Biotech Cluster in Wallonia
France Fannes, Managing Director, BioWin

1:30pm | Belgian and US Biotech Company Presentations
          Disease-modifying Treatments Against Alzheimer's, Parkison's, Diabetes
               and Other Protein Misfolding Disorders
          Koen De Witte, CEO, ReMynd

          Novel Approaches to Treating Alzheimer’s and Parkinson’s Disease
          Michel Levesque & Mohamedi Kagalwala, NeuroGeneration

          Trusted and Innovative Solutions for Diagnostics and Biopharmaceuticals
          Luc Marion, Senior Manager Diagnostic Services, Eurogentec

          Next Generation Vision Correcting Treatment
               and other Protein misfolding Disorders
          Alberto Osio, CEO, Yolia Health

          Amgen, Nobel Prize chemistry 2012 and Many Other Californian Partners:
               Pillars of the UCB Innovation Model
          Didier Malherbe, Vice President UCB and General Manager UCB Belgium
2:30pm | Reception

3:30pm | Close

Janssen Research & Development LLC
3210 Merryfield Row
San Diego, CA 92121

*Registration is limited, please register early*